Answers are grounded in this paper and cite their sources.
High-dose systemic prednisolone therapy in infants may cause reversible hypertrophic obstructive cardiomyopathy.
A 3-month-old infant was administered high-dose systemic prednisolone for management of a hemangioma of the nasal sidewall. After 10 weeks of therapy, medical evaluation of weight loss disclosed hypertrophic obstructive cardiomyopathy. After discontinuation of the steroid, the cardiomyopathy resolved.
No takes yet. Share an insight, caveat, or question.
Pokorny et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: